Total Payments
$7,818
2024 Payments
$778.72
Companies
32
Transactions
304
Medicare Patients
11,922
Medicare Billing
$1.2M
Payment Breakdown by Category
Food & Beverage$5,751 (73.6%)
Other$1,120 (14.3%)
Gifts$935.00 (12.0%)
Education$12.70 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,751 | 290 | 73.6% |
| Gift | $935.00 | 3 | 12.0% |
| Entertainment | $584.47 | 2 | 7.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $535.32 | 8 | 6.8% |
| Education | $12.70 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,243 | 37 | $0 (2024) |
| Sekisui Diagnostics, LLC | $935.00 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $693.33 | 45 | $0 (2024) |
| Flowonix Medical Incorporated | $629.26 | 3 | $0 (2020) |
| GlaxoSmithKline, LLC. | $523.67 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $455.00 | 3 | $0 (2017) |
| PFIZER INC. | $433.51 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $370.05 | 15 | $0 (2022) |
| Lilly USA, LLC | $274.87 | 18 | $0 (2023) |
| Genentech USA, Inc. | $261.01 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $778.72 | 31 | Sekisui Diagnostics, LLC ($200.00) |
| 2023 | $1,095 | 31 | Sekisui Diagnostics, LLC ($550.00) |
| 2022 | $1,115 | 48 | Sekisui Diagnostics, LLC ($185.00) |
| 2021 | $777.87 | 37 | Novo Nordisk Inc ($198.73) |
| 2020 | $516.82 | 32 | AstraZeneca Pharmaceuticals LP ($101.29) |
| 2019 | $1,180 | 34 | Flowonix Medical Incorporated ($501.80) |
| 2018 | $668.79 | 36 | Novo Nordisk Inc ($195.86) |
| 2017 | $1,685 | 55 | SANOFI-AVENTIS U.S. LLC ($455.00) |
All Payment Transactions
304 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Respiratory | ||||||
| 11/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Opioid Analgesic | ||||||
| 10/22/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.82 | General |
| Category: Opioid Analgesic | ||||||
| 08/08/2024 | Digestive Care, Inc. | Pertzye (Drug), Pertzye, Pertzye | Food and Beverage | Cash or cash equivalent | $18.36 | General |
| Category: Gastroenterology | ||||||
| 08/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Inflammation | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Biological | ||||||
| 07/15/2024 | Sekisui Diagnostics, LLC | — | Gift | Cash or cash equivalent | $200.00 | General |
| 06/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Cardio-renal | ||||||
| 06/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: Diabetes | ||||||
| 05/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Inflammation | ||||||
| 05/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Cardio-renal | ||||||
| 05/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Biological | ||||||
| 04/10/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $26.58 | General |
| Category: Cardiovascular | ||||||
| 03/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: RESPIRATORY | ||||||
| 03/18/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Respiratory | ||||||
| 03/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 2,343 | 4,286 | $607,549 | $259,563 |
| 2022 | 28 | 2,764 | 4,759 | $688,950 | $286,631 |
| 2021 | 35 | 3,300 | 5,395 | $760,257 | $354,025 |
| 2020 | 37 | 3,515 | 6,208 | $757,842 | $315,120 |
Total Patients
11,922
Total Services
20,648
Medicare Billing
$1.2M
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 406 | 957 | $180,873 | $76,473 | 42.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 167 | 284 | $75,828 | $35,518 | 46.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 130 | 261 | $72,045 | $23,986 | 33.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 136 | 136 | $26,248 | $16,963 | 64.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 53 | 357 | $33,558 | $16,647 | 49.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 139 | 145 | $41,561 | $12,583 | 30.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 92 | 92 | $30,084 | $12,541 | 41.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 133 | 136 | $13,600 | $10,212 | 75.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 45 | 49 | $20,090 | $9,745 | 48.5% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 33 | 33 | $14,037 | $9,297 | 66.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 64 | 67 | $35,930 | $8,975 | 25.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 28 | 47 | $30,169 | $7,739 | 25.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 139 | 142 | $6,248 | $4,203 | 67.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 87 | 217 | $7,378 | $3,456 | 46.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 131 | 256 | $3,840 | $2,418 | 63.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 128 | 128 | $3,584 | $2,276 | 63.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 196 | 528 | $2,640 | $1,688 | 64.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 27 | $3,618 | $1,218 | 33.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 39 | 39 | $1,716 | $1,163 | 67.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 45 | 45 | $1,215 | $800.10 | 65.9% |
| 85610 | Blood test, clotting time | Office | 2023 | 25 | 163 | $978.00 | $680.40 | 69.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 24 | 61 | $1,281 | $576.64 | 45.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 27 | 28 | $588.00 | $212.75 | 36.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 35 | 44 | $220.00 | $150.04 | 68.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 14 | 44 | $220.00 | $42.49 | 19.3% |
About Dr. Leon Driss, MD
Dr. Leon Driss, MD is a Hospitalist healthcare provider based in Show Low, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669445706.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Leon Driss, MD has received a total of $7,818 in payments from pharmaceutical and medical device companies, with $778.72 received in 2024. These payments were reported across 304 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($5,751).
As a Medicare-enrolled provider, Driss has provided services to 11,922 Medicare beneficiaries, totaling 20,648 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Other Specialties Internal Medicine
- Location Show Low, AZ
- Active Since 02/09/2006
- Last Updated 06/18/2024
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1669445706
Products in Payments
- Prometra II (Device) $629.26
- Tresiba (Drug) $408.58
- Ozempic (Drug) $401.44
- SOLIQUA (Drug) $395.00
- TRELEGY ELLIPTA (Drug) $351.83
- FARXIGA (Drug) $344.36
- Kerendia (Drug) $249.73
- Prolastin-C Liquid (Biological) $228.04
- ELIQUIS (Drug) $187.73
- RYBELSUS (Drug) $183.26
- PREVNAR 20 (Biological) $175.46
- XARELTO (Drug) $165.66
- Xolair (Biological) $142.58
- BREZTRI (Drug) $132.58
- TRULICITY (Drug) $117.02
- Xultophy 100/3.6 (Drug) $113.39
- BEVESPI AEROSPHERE (Drug) $102.92
- STIOLTO RESPIMAT (Drug) $97.19
- AVYCAZ (Drug) $96.93
- Yupelri (Drug) $90.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.